Epstein.Interpretación de biopsias de la próstata, 6ed

211

INFORME DEL CÁNCER 

79. Ng JC, Koch MO, Daggy JK, et al. Perineural invasion in radical prostatectomy specimens: lack of prognostic significance. J Urol . 2004;172(6, pt 1):2249–2251. 80. O’Malley KJ, Pound CR,Walsh PC, et al. Influence of biopsy perineural invasion on long-term bioche- mical disease-free survival after radical prostatectomy. Urology . 2002;59(1):85–90. 81. McNeal JE, Yemoto CE. Significance of demonstrable vascular space invasion for the progression of prostatic adenocarcinoma. Am J Surg Pathol . 1996;20(11):1351–1360. 82. van den Ouden D, Kranse R, Hop WC, et al. Microvascular invasion in prostate cancer: prognostic significance in patients treated by radical prostatectomy for clinically localized carcinoma. Urol Int . 1998;60(1):17–24. 83. de la Taille A, Rubin MA, Buttyan R, et al. Is microvascular invasion on radical prostatectomy speci- mens a useful predictor of PSA recurrence for prostate cancer patients? Eur Urol . 2000;38(1):79–84. 84. Babaian RJ, Troncoso P, Bhadkamkar VA, et al. Analysis of clinicopathologic factors predicting outcome after radical prostatectomy. Cancer . 2001;91(8):1414–1422. 85. Ferrari MK, McNeal JE, Malhotra SM, et al. Vascular invasion predicts recurrence after radical prostatectomy: stratification of risk based on pathologic variables. Urology . 2004;64(4):749–753. 86. Cheng L, Jones TD, Lin H, et al. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma. J Urol . 2005;174(6):2181–2185. 87. Brooks JP, Albert PS, O’Connell J, et al. Lymphovascular invasion in prostate cancer: prognostic significance in patients treated with radiotherapy after radical prostatectomy. Cancer . 2006;106(7): 1521–1526. 88. Loeb S, Roehl KA, Yu X, et al. Lymphovascular invasion in radical prostatectomy specimens: pre- diction of adverse pathologic features and biochemical progression. Urology . 2006;68(1):99–103. 89. May M, Kaufmann O, Hammermann F, et al. Prognostic impact of lymphovascular invasion in ra- dical prostatectomy specimens. BJU Int . 2007;99(3):539–544. 90. Roma AA, Magi-Galluzzi C, Kral MA, et al. Peritumoral lymphatic invasion is associated with regional lymph node metastases in prostate adenocarcinoma. Mod Pathol . 2006;19(3):392–398. 91. Fajkovic H, Mathieu R, Lucca I, et al. Validation of lymphovascular invasion is an independent prognostic factor for biochemical recurrence after radical prostatectomy. Urol Oncol .2016;34(5):233. e1–233.e6. 92. Ross PL, Scardino PT, Kattan MW. A catalog of prostate cancer nomograms. J Urol . 2001; 165(5):1562–1568. 93. Partin AW, Kattan MW, Subong EN, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA . 1997;277(18):1445–1451. 94. Stephenson AJ, Scardino PT, Eastham JA, et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst . 2006; 98(10):715–717. 95. D’Amico AV, Whittington R, Malkowicz SB, et al. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer. Urology . 2000;55(4):572–577. 96. Kattan MW, Zelefsky MJ, Kupelian PA, et al. Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer. J Clin Oncol . 2000;18(19):3352–3359. 97. Kattan MW, Eastham JA, Stapleton AM, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst . 1998;90(10):766–771. 98. Eifler JB, Feng Z, Lin BM, et al. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011. BJU Int . 2013;111(1):22–29. 99. Sadimin ET, Ye H, Epstein JI. Should the involvement of skeletal muscle by prostatic adenocarci- noma be reported on biopsies? Hum Pathol . 2016;49:10–14. 100. Ye H, Walsh PC, Epstein JI. Skeletal muscle involvement by limited Gleason score 6 adenocarci- noma of the prostate on needle biopsy is not associated with adverse findings at radical prostatec- tomy. J Urol . 2010;184(6):2308–2312. SAMPLE